• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Replacement Heart Valves

Abbott earns Medicare win for TriClip TEER system

July 10, 2025 By Sean Whooley

Abbott announced that it received a Medicare win related to its TriClip TEER system.  In a LinkedIn post, the company’s Cardiovascular unit wrote that the Centers for Medicare and Medicaid Services (CMS) released a National Coverage Determination (NCD) and coverage conditions for tricuspid transcatheter edge-to-edge repair (T-TEER) for tricuspid regurgitation (TR). That included the company’s […]

Filed Under: Cardiac Implants, Cardiovascular, Medicare, Replacement Heart Valves, Structural Heart Tagged With: Abbott

Caranx Medical surgical robot TaviPilot AI software wins FDA clearance

July 9, 2025 By Sean Whooley

The FDA has granted 510(k) clearance to the TaviPilot AI software developed by Caranx Medical, according to company officials. Pierre Berthet-Rayne, the company’s co-founder and chief technology officer, announced the clearance on LinkedIn. Nice, France-based Caranx Medical developed its TaviPilot robotic solution for aortic valve replacement. The robot can make an artery puncture and then, […]

Filed Under: 510(k), Artificial Intelligence (AI), Cardiac Implants, Cardiovascular, Food & Drug Administration (FDA), Health Technology, Imaging, Machine Learning (ML), Regulatory/Compliance, Replacement Heart Valves, Software / IT, Structural Heart Tagged With: Caranx Medical

MiRus reports positive early feasibility data for heart valve

July 3, 2025 By Sean Whooley

MiRus announced new early feasibility study results supporting the use of its Siegel transcatheter aortic valve replacement (TAVR) system. Dr. Pradeep Yadav (Piedmont Heart Institute) and Dr. Raj Makkar (Cedars Sinai) presented findings in podium presentations at NY Valves. Thirty-day results came from the company’s U.S. early feasibility study (EFS). MiRus announced the start of […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Implants, Replacement Heart Valves, Structural Heart Tagged With: mirus

CroíValve picks up new funding from European accelerator

July 2, 2025 By Sean Whooley

CroíValve announced today that it received new funding from Horizon Europe’s European Innovation Council (EIC) Accelerator Program. EIC awarded the funding as part of the EU’s Horizon Europe 2021-2027 Research and Innovation Program. It provides funding to high-potential, high-risk startups, scale-ups and subject matter experts. The competition included 959 applicants for 40 awards across 16 […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Funding Roundup, Replacement Heart Valves, Structural Heart Tagged With: croivalve

Foldax presents positive polymer heart valve data

June 27, 2025 By Sean Whooley

Foldax today announced one-year results from a clinical trial of its Tria polymer mitral heart valve offering. In a trial based in India, the mitral valve demonstrated a good safety profile and sustained hemodynamic performance. Investigators reported a statistically significant improvement in patient quality of life. “These results validate our strategy of taking heart valve therapy […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Implants, Replacement Heart Valves, Structural Heart Tagged With: foldax

Court sides with Cardiovalve in Edwards patent spat

June 10, 2025 By Sean Whooley

The U.S. Court of Appeals for the Federal Circuit has taken Cardiovalve’s side after Edwards argued certain heart valve patent claims were invalid. In a final written decision, the U.S. Patent Trial and Appeal Board (PTAB) granted Cardiovalve’s non-contingent motion to amend and supplemental motion to amend, canceling original claims in U.S. Patent No. 10,702,385. […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Legal News, Patent Infringement, Replacement Heart Valves, Structural Heart Tagged With: cardiovalve, Edwards Lifesciences

Foldax gets India approval for polymer mitral heart valve

June 6, 2025 By Danielle Kirsh

Foldax this week announced it secured regulatory approval in India for its Tria mitral heart valve. The approval from India’s Central Drugs Standard Control Organization allows Dolphin Life Science to produce the valve locally. It is the first commercial approval of a polymer heart valve anywhere in the world, according to the company. Foldax designed […]

Filed Under: Cardiovascular, Regulatory/Compliance, Replacement Heart Valves Tagged With: foldax

Designer of the first artificial heart Robert Jarvik passes away

June 2, 2025 By Sean Whooley

The New York Times reported last week that Dr. Robert K. Jarvik, who led the development of the first artificial heart, passed away. He died last Monday at his home in Manhattan at the age of 79, according to the report. His wife, Marilyn vos Savant, told The New York Times that he died of […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Implants, Replacement Heart Valves, Structural Heart Tagged With: artificial hearts

BiVacor wins FDA breakthrough nod for Total Artificial Heart

May 30, 2025 By Sean Whooley

BiVacor announced today that it received FDA breakthrough device designation for its Total Artificial Heart (TAH) system. The designation supports the TAH as a bridge to transplant (BTT) for adults with severe biventricular or univentricular heart failure where current treatments, including LVADs, are not viable. “This is more than a regulatory milestone. It’s a validation […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Food & Drug Administration (FDA), Implants, Regulatory/Compliance, Replacement Heart Valves, Structural Heart Tagged With: bivacor, FDA

FDA approves Abbott mitral valve replacement device that doesn’t require open-heart surgery

May 27, 2025 By Sean Whooley

Abbott announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR) system. The TMVR system offers an option for patients with mitral valves that fail to function properly due to severe mitral annular calcification (MAC). MAC stiffens the annulus ring-like structure that supports the mitral valve. This can lead to […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Food & Drug Administration (FDA), Implants, Regulatory/Compliance, Replacement Heart Valves, Structural Heart Tagged With: Abbott, FDA, nitinol

The biggest cardiovascular tech news out of EuroPCR 2025

May 23, 2025 By Sean Whooley

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR 2025 in Paris. The latest edition of EuroPCR delivered updates on technologies like intravascular lithotripsy (IVL), replacement heart valves, drug-eluting stents and many, many more innovative offerings. Usual suspects in the cardiovascular space like Edwards, Johnson & […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Clinical Trials, Drug-Eluting Stents, Featured, Implants, Regulatory/Compliance, Replacement Heart Valves, Stents, Structural Heart, Ultrasound, Vascular Tagged With: Boston Scientific, cardiawave, Edwards Lifesciences, Elixir Medical, EuroPCR 2025, Johnson & Johnson, Johnson & Johnson MedTech, Medtronic, Meril, Meril Life Science, Shockwave Medical, TriCares

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 90
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy